Dynorphin A: inhibitory effect on other opiate ligand bindings in the mouse brain.
The opioid peptide dynorphin A antagonizes morphine-induced analgesia in vivo and inhibits opiate binding in vitro, although most of it is rapidly degraded under both conditions. The inhibitory effect was present even in tissue treated in vivo with dynorphin A and assayed in vitro without it. Shorter fragments of this peptide lacked these effects, indicating that the apparent potency did not result from a metabolite. Na+ ion specifically reversed both agonist and antagonist binding from in vitro inhibition by dynorphin A. These results are discussed in terms of current opioid receptor theories.
D000818:Animals; D001921:Brain / Q000378:metabolism*; D003496:Cyclazocine / Q000031:analogs & derivatives / Q000378:metabolism; D004399:Dynorphins; D004723:Endorphins / Q000494:pharmacology*; D016314:Ethylketocyclazocine; D066298:In Vitro Techniques; D008024:Ligands; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D009270:Naloxone / Q000378:metabolism; D009294:Narcotics / Q000378:metabolism*; D010446:Peptide Fragments / Q000494:pharmacology*; D011957:Receptors, Opioid / Q000378:metabolism; D012965:Sodium Chloride / Q000494:pharmacology
D004723:Endorphins; D008024:Ligands; D009294:Narcotics; D010446:Peptide Fragments; D011957:Receptors, Opioid; D009270:Naloxone; D012965:Sodium Chloride; D016314:Ethylketocyclazocine; C026843:dynorphin (1-13); D004399:Dynorphins; D003496:Cyclazocine